piperacillin has been researched along with Bacterial Infections, Gram-Negative in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (12.66) | 18.2507 |
2000's | 34 (43.04) | 29.6817 |
2010's | 32 (40.51) | 24.3611 |
2020's | 3 (3.80) | 2.80 |
Authors | Studies |
---|---|
Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F | 1 |
Courvalin, P; Dupêchez, M; Galimand, M; Lambert, T; Meziane-Cherif, D | 1 |
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
Brown, NP; Pillar, CM; Sahm, DF; Shah, D; Torres, MK | 1 |
Amicosante, G; De Luca, F; Luzzaro, F; Migliavacca, R; Mugnaioli, C; Pagani, L; Perilli, M; Pini, B; Pollini, S; Rossolini, GM; Spalla, M; Toniolo, A | 1 |
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR; Paterson, DL | 1 |
Eb, F; Guillon, H; Mammeri, H | 1 |
Bazan, NS; Elmazar, MM; Naiim, CM; Sabri, NA | 1 |
Assanelli, AA; Bernardi, M; Carletti, S; Carrabba, MG; Castagna, A; Ciceri, F; Clerici, D; Corti, C; Erbella, F; Farina, F; Galli, L; Giglio, F; Greco, R; Liberatore, C; Lorentino, F; Lugli, AP; Lupo Stanghellini, MT; Mancini, N; Mastaglio, S; Nitti, R; Oltolini, C; Peccatori, J; Poli, A; Ripa, M; Ruggeri, A; Scarpellini, P; Tassan Din, C; Xue, E | 1 |
Bruniera, FR; Costa, SF; Cury, AP; Higashino, H; Mendes, FR; Oliveira, FN; Rizeck, C; Rocha, V; Rossi, F; Schmidt, J | 1 |
Ahir, H; Foo, J; Merchant, S; Prabhu, V; Sarpong, E | 1 |
Feizabadi, MM; Ghodousi, A; Haeili, M; Nomanpour, B; Omrani, M | 1 |
Chang, SW; Chen, PR; Kuo, HY; Liou, ML; Liu, CC; Pien, CJ; Yeh, HW | 1 |
Khardori, N; Shahani, L | 1 |
Ahuja, T; Chen, D; Chen, XJ; Cutro, SR; Dubrovskaya, Y; Holzman, R; Mehta, SA; Papadopoulos, J; Phillips, MS; Scipione, MR | 1 |
Hong, SK; Kim, EC; Kim, JA | 1 |
Conte, V; D'Inzeo, T; De Angelis, G; Di Florio, V; Fiori, B; Giani, T; Giaquinto, A; Palucci, I; Rossolini, GM; Sanguinetti, M; Santangelo, R; Scoppettuolo, G; Spanu, T | 1 |
Abu-Seir, H; Gregg, KS; Hough, SM; Marini, BL; Nagel, JL | 1 |
Han, XY; Li, L; Tarrand, JJ | 1 |
Sadikot, RT; Swenson, CE | 1 |
Baek, JY; Sohn, KM | 1 |
Du, Y; Guo, W; He, J; He, Q; Wang, Z; Wei, M; Wu, C; Yang, Z | 1 |
Awais, M; Rehman, A; Ul-Ain Baloch, N | 1 |
D'Agostino, C; Rhodes, NJ; Roberts, JA; Scheetz, MH; Skoglund, E | 1 |
Duane, TM; Kikhia, RM; Ober, J; Tessier, JM; Wolfe, LG | 1 |
Bork, JT; D'Angelo, RG; Heil, EL; Johnson, JK | 1 |
Merluzzi, S; Pagotto, A; Pillinini, P; Valeri, M | 1 |
Karino, S; Kaye, KS; Koppula, S; Martin, ET; Murray, KP; Mynatt, RP; Navalkele, B; Nishan, B; Pervaiz, A; Pogue, JM; Rybak, MJ; Salim, M; Shaikh, H; Solanki, S; Tashtoush, N | 1 |
Abelleira, M; Castelli, J; Etlin, A; Gerona, S; González, LS; Grecco, G; Harguindeguy, M; Iglesias, C; Leites, A; López, M; Medina, JC; Menéndez, J; Prieto, J; Rando, K; Scalone, P; Valverde, M | 1 |
Hickson, RP; Judd, WR; Mueller, JE; Ratliff, PD; Winstead, EM | 1 |
Burgess, DS; Frei, CR | 2 |
Enbawe, S; Lat, A; Lodise, TP; Manor, K; Patel, GW; Patel, N; Smith, R; Trombley, K | 1 |
Cheatham, SC; Kays, MB; Shea, KM; Smith, DW; Sowinski, KM; Wack, MF | 2 |
Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC | 1 |
Foley, RJ; Kannan, S; Kourelis, T | 1 |
Clark, NM; Garofalo, J; Grim, SA; Heinrich, LS; Paek, JL; Tokumaru, S | 1 |
Cappelletty, DM; Yost, RJ | 1 |
Baykan, M; Demircili, ME; Feyzioğlu, B; Özdemir, M; Pekcan, S; Pirinç, Ş; Taşbent, FE | 1 |
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW | 1 |
Adams, CA; Cioffi, WG; Connolly, MD; Gregg, S; Heffernan, DS; Monaghan, SF; Stephen, A; Thakkar, RK | 1 |
Lee, GC; Liou, H; Neldner, K; Quan, CF; Yee, R | 1 |
Blake, P; Brichacek, M; Kao, R | 1 |
Arnold, HM; Hampton, NB; Hoban, A; Hoffmann, J; Hollands, JM; Juang, PH; Kollef, MH; McCormick, S; Micek, ST; Reichley, RM; Skrupky, LP; Smith, JR | 1 |
Akashi, K; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H | 1 |
Dul, MJ; Hoyen, C; Salvator, A; Toltzis, H; Toltzis, P; Walsh, M; Zetts, L | 1 |
Carides, A; Choe, KA; Christou, NV; Dellinger, EP; Fernandez, A; Malafaia, O; Rotstein, OD; Satishchandran, V; Solomkin, JS; Tellado, JM; Teppler, H; Yellin, AE | 1 |
Chalkley, LJ; Theron, MM; van Rensburg, MN | 1 |
Apfalter, P; Berger, A; Kretzer, V; Pollak, A; Rohrmeister, K; Zaknun, D | 1 |
Bernaldez, R; Collado, D; Rodrigo, JP; Sŭrez, C | 1 |
Chang, SW; Chen, YF; Hsiao, CH; Huang, ZL; Lin, KK | 1 |
Dittrich, E; Guttmann, C; Meyer, B; Schmaldienst, S; Thalhammer, F | 1 |
Chan, CY; Dinubile, MJ; Friedland, I; Giezek, H; Motyl, MR; Quinn, JP; Shivaprakash, M; Weinstein, RA | 1 |
Chien, CC; Kuo, CY; Liu, JW; Tsai, MS; Wang, MC; Wu, HC | 1 |
Barra, D; Bozzi, A; Cirioni, O; Di Giulio, A; Ghiselli, R; Giacometti, A; Luzi, C; Mangoni, ML; Mocchegiani, F; Orlando, F; Rinaldi, AC; Saba, V; Scalise, G; Silvestri, C | 1 |
Fazeli, MR; Gholami, K; Mojtahedzadeh, M; Najafi, A; Rafati, MR; Rouini, MR; Tavakoli, H | 1 |
Choudhri, S; Herrington, J; Malangoni, MA; Pertel, P; Song, J | 1 |
Alexaki, P; Alivizatos, AS; Athanasiou, AE; Chalkiopoulou, I; Christakis, GB; Zarkadis, IK | 1 |
McAllum, P; Poutanen, SM; Slomovic, AR; Srinivasan, S | 1 |
Araujo, VR; Carvalho-Dias, VM; Cunha, CA; de Souza, CA; de Souza, M; Godoy, C; Lotfi, CJ; Maiolino, A; Nucci, M; Oliveira, AL; Pasquini, R; Ruiz, MA; Seber, A; Silla, L; Simões, BP; Tanaka, PY; Trabasso, P; Urakawa, P; Zanichelli, MA | 1 |
Harada, AS; Lau, W | 1 |
Erba, P; Hintermann, B; Kalbermatten, DF; Laifer, G; Pierer, G; Rieger, UM; Uike, K | 1 |
Afonso, MR; Albertoni, Ade C; Arkader, R; Cabral, EA; da Silva, DC; de Araujo, OR; Diegues, AR; Louzada, ME | 1 |
Bennett, KM; Dodds-Ashley, E; Hayward, TZ; Kaye, KS; Scarborough, JE; Sharpe, M; Vaslef, SN | 1 |
Cahen, P; Dardelle, D; Gravisse, J; Honderlick, P | 1 |
Jakob, E; Jáuregui, A; Rojas, JJ; Ruíz-Palacios, GM; Sifuentes-Osornio, J; Villalobos, Y | 1 |
Chandy, M; Ebenezer, S; Jesudason, MV; Lalitha, MK | 1 |
De Pauw, BE; Deresinski, SC; Donnelly, JP; Feld, R; Lane-Allman, EF | 1 |
Georgieff, M; Konrad, F; Neumeister, B; Rommel, H; Wagner, R | 1 |
Hanaki, H; Nagayama, A; Nomura, S | 1 |
Donazzan, M; Ferri, F; Rose, C; Tellion, C | 1 |
Aznar, E; Climent, MA; Máiquez, J; Palau, J; Picón, I | 1 |
Carinder, JE; Chua, JD; Corales, RB; Procop, GW; Taege, AJ | 1 |
Cirioni, O; Del Prete, MS; Fineo, A; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G | 1 |
Bateman, JM; Masterton, RG; Rainford, DJ | 1 |
Andremont, A; Azab, M; Boutan-Laroze, A; Droz, JP; Kattan, J; Ribrag, V | 1 |
Kelsey, SM; Newland, AC; Shaw, E | 1 |
Bruckner, DA; Champlin, RE; Ho, WG; Winston, DJ | 1 |
7 review(s) available for piperacillin and Bacterial Infections, Gram-Negative
Article | Year |
---|---|
Capnocytophaga sputigena bloodstream infection in hematopoietic stem cell transplantations: two cases report and review of the literature.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Capnocytophaga; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Meropenem; Middle Aged; Mucositis; Neutrophils; Piperacillin; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tazobactam; Transplantation, Autologous | 2020 |
Achromobacter respiratory infections.
Topics: Achromobacter; Age Factors; Anti-Bacterial Agents; Bronchiectasis; Cefoperazone; Cephalosporins; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Neoplasms; Penicillins; Piperacillin; Pneumonia, Bacterial; Respiratory Tract Infections; Risk Factors; Sex Factors; Ticarcillin; Virulence Factors | 2015 |
Delftia lacustris septicemia in a pheochromocytoma patient: case report and literature review.
Topics: Adrenal Gland Neoplasms; Aged; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Delftia; DNA, Bacterial; DNA, Ribosomal; Gram-Negative Bacterial Infections; Humans; Male; Penicillanic Acid; Pheochromocytoma; Piperacillin; RNA, Ribosomal, 16S; Sepsis; Sequence Analysis, DNA; Tazobactam | 2015 |
Severe ovarian hyperstimulation syndrome complicated by Stenotrophomonas maltophilia peritonitis: a case report and literature review.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Female; Gram-Negative Bacterial Infections; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Stenotrophomonas maltophilia; Treatment Outcome | 2015 |
Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2016 |
Bloodstream infection with Oligella ureolytica: a case report and review of the literature.
Topics: Aged; Alcaligenaceae; Anti-Bacterial Agents; Aortic Valve Stenosis; Bacteremia; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Male; Penicillanic Acid; Piperacillin; Risk Factors; Tazobactam; Treatment Outcome | 2016 |
Rahnella aquatilis bacteremia in a patient with relapsed acute lymphoblastic leukemia.
Topics: Bacteremia; Bone Marrow Transplantation; Burkitt Lymphoma; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rahnella | 2001 |
13 trial(s) available for piperacillin and Bacterial Infections, Gram-Negative
Article | Year |
---|---|
Extended infusion of piperacillin-tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study.
Topics: Anti-Bacterial Agents; Cost-Benefit Analysis; Critical Illness; Egypt; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 2022 |
Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cohort Studies; Cross Infection; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Teaching; Hospitals, Urban; Humans; Infusions, Intravenous; Intensive Care Units; Length of Stay; Male; Meropenem; Middle Aged; Missouri; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2013 |
Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefepime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Meropenem; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins | 2013 |
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Digestive System Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Ertapenem; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitalization; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Research Design; Treatment Outcome | 2003 |
Efficacy of piperacillin-tazobactam in the treatment of surgical wound infection after clean-contaminated head and neck oncologic surgery.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Head and Neck Neoplasms; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Surgical Wound Infection; Treatment Outcome | 2004 |
Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carrier State; Ceftriaxone; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intestines; Lactams; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2005 |
Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Critical Illness; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Sepsis; Severity of Illness Index; Treatment Outcome | 2006 |
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.
Topics: Abdominal Abscess; Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendicitis; Aza Compounds; Bacterial Infections; Cross Infection; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Intestinal Perforation; Male; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Quinolines; Safety; Stomach Rupture; Treatment Outcome | 2006 |
Piperacillin/tazobactam in the treatment of lower respiratory tract infections: an open non-comparative and multicentered trial. Latin American Clinical Research Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Respiratory Tract Infections | 1994 |
Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.
Topics: Adult; Bacteremia; Ceftazidime; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Odds Ratio; Piperacillin; Superinfection; Tobramycin; Treatment Outcome | 1994 |
Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Neoplasms; Neutropenia; Pefloxacin; Piperacillin; Vancomycin | 1992 |
Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study.
Topics: Adult; Aztreonam; Bacteremia; Drug Therapy, Combination; Fever; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Piperacillin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1992 |
Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Ceftazidime; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Superinfection | 1991 |
59 other study(ies) available for piperacillin and Bacterial Infections, Gram-Negative
Article | Year |
---|---|
Antimicrobial susceptibilities and clinical sources of Dialister species.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae | 2007 |
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Brachyspira; Cloning, Molecular; Diarrhea; Feces; Gram-Negative Bacterial Infections; Humans; Kinetics; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Sequence Analysis, DNA | 2008 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.
Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; United States | 2008 |
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
Topics: Base Sequence; beta-Lactam Resistance; beta-Lactamases; Data Collection; DNA Primers; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Integrons; Italy; Molecular Epidemiology; Molecular Sequence Data | 2008 |
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Imipenem; India; Klebsiella; Quinolones; Thailand | 2009 |
Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.
Topics: Amino Acid Sequence; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Capnocytophaga; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis | 2010 |
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB.
Topics: Anti-Infective Agents; Carbapenems; Cohort Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Neutropenia; Piperacillin; Retrospective Studies; Tazobactam; Transplantation, Homologous | 2023 |
Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Cephalosporins; Clinical Protocols; Drug Combinations; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Male; Metronidazole; Models, Econometric; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality-Adjusted Life Years; Tazobactam; United Kingdom | 2017 |
Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ceftriaxone; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals; Humans; Iran; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Polymyxin B; Prevalence; Pseudomonas aeruginosa; Respiratory Tract Infections; Sputum; Staphylococcus aureus | 2013 |
Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Female; Gram-Negative Bacterial Infections; Hospitals; Humans; Levofloxacin; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Respiratory Tract Infections; Risk Factors; Sputum; Stenotrophomonas maltophilia | 2015 |
Overwhelming Capnocytophaga canimorsus infection in a patient with asplenia.
Topics: Animals; Anti-Bacterial Agents; Capnocytophaga; Dogs; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Male; Middle Aged; Penicillanic Acid; Pets; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Splenectomy; Zoonoses | 2014 |
Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.
Topics: Aged; Anti-Bacterial Agents; Cost-Benefit Analysis; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Length of Stay; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Survival Analysis; Syndrome; Tertiary Healthcare | 2014 |
Capnocytophaga sputigena bacteremia in a patient with chronic lymphocytic leukemia.
Topics: Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Capnocytophaga; Gram-Negative Bacterial Infections; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Sequence Homology, Nucleic Acid; Tazobactam; Transplantation, Homologous; Treatment Outcome | 2014 |
Catheter-related bacteremia by Cupriavidus metallidurans.
Topics: Adult; Aged; Bacteremia; Catheter-Related Infections; Cupriavidus; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tazobactam | 2015 |
Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Middle Aged; Neoplasms; Penicillanic Acid; Penicillin Resistance; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Young Adult | 2015 |
Microbiological and clinical features of four cases of catheter-related infection by Methylobacterium radiotolerans.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Catheter-Related Infections; Child; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Methylobacterium; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Young Adult | 2015 |
Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ceftazidime; China; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Utilization Review; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Inpatients; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Tertiary Care Centers | 2015 |
Microbiologic clearance following transition from standard infusion piperacillin-tazobactam to extended-infusion for persistent Gram-negative bacteremia and possible endocarditis: A case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Endocarditis; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2015 |
Understanding Gram-negative Central Line-Associated Blood Stream Infection in a Surgical Trauma ICU.
Topics: Adult; Aged; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Cohort Studies; Comprehension; Cross Infection; Female; Follow-Up Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; Survival Rate; Tertiary Care Centers; Treatment Outcome; Urban Population; Virginia | 2015 |
Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Michigan; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2016 |
Impact of a Multimodal Approach in Prevention of Surgical Site Infection in Hepatic Transplant Recipients.
Topics: Administration, Cutaneous; Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Cefazolin; Chlorhexidine; Drug Administration Schedule; Drug Therapy, Combination; Ether; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Liver Transplantation; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Transplant Recipients | 2016 |
Evaluation of an alternative extended-infusion piperacillin-tazobactam dosing strategy for the treatment of gram-negative infections.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Delayed-Action Preparations; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Kentucky; Male; Middle Aged; Patient Readmission; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome | 2016 |
Pharmacokinetic/pharmacodynamic modeling to predict in vivo effectiveness of various dosing regimens of piperacillin/tazobactam and piperacillin monotherapy against gram-negative pulmonary isolates from patients managed in intensive care units in 2002.
Topics: Acinetobacter baumannii; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Drug Therapy, Combination; Enterobacteriaceae; Gram-Negative Bacterial Infections; Half-Life; Humans; Intensive Care Units; Lung Diseases; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Patient Admission; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; United States | 2008 |
Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome | 2009 |
Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Inpatients; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Serum; United States | 2009 |
Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patients.
Topics: Adult; Aged; Drug Administration Schedule; Gram-Negative Bacterial Infections; Hospitalization; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Penicillanic Acid; Piperacillin; Tazobactam | 2009 |
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic | 2010 |
An unusual case of septic shock in a geriatric patient.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Antidiuretic Agents; Capnocytophaga; Female; Fluid Therapy; Gram-Negative Bacterial Infections; Humans; Multiple Organ Failure; Penicillanic Acid; Piperacillin; Risk Factors; Shock, Septic; Tazobactam; Vancomycin; Vasopressins | 2010 |
Development and implementation of a piperacillin-tazobactam extended infusion guideline.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guideline Adherence; Health Plan Implementation; Humans; Infusions, Intravenous; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Time Factors; Young Adult | 2011 |
The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.
Topics: Aged; Anti-Bacterial Agents; Cohort Studies; Female; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome | 2011 |
A rare cause of bacteremia in a pediatric patient with Down syndrome: Sphingomonas paucimobilis.
Topics: Bacteremia; Cross Infection; Down Syndrome; Gram-Negative Bacterial Infections; Humans; Infant; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Sphingomonas | 2011 |
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Topics: Amikacin; Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Prospective Studies; Urinary Tract Infections | 2012 |
Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Topics: Acetamides; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tazobactam; Treatment Outcome; Vancomycin; Wounds and Injuries | 2013 |
Outcomes of extended-infusion piperacillin-tazobactam: a retrospective analysis of critically ill patients.
Topics: Aged; Anti-Bacterial Agents; Critical Illness; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2012 |
Capnocytophaga canimorsus infection presenting with complete splenic infarction and thrombotic thrombocytopenic purpura: a case report.
Topics: Aged; Animals; Anti-Bacterial Agents; Bites and Stings; Capnocytophaga; Dogs; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Purpura, Thrombotic Thrombocytopenic; Splenic Infarction; Thienamycins | 2012 |
The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Penicillanic Acid; Pharynx; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rectum | 2002 |
Penicillin-binding proteins involved in high-level piperacillin resistance in Veillonella spp.
Topics: Ampicillin; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Gram-Negative Bacterial Infections; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Piperacillin; Veillonella | 2003 |
Safety evaluation of piperacillin/tazobactam in very low birth weight infants.
Topics: Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Therapy, Combination; Enterocolitis, Necrotizing; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Infant, Very Low Birth Weight; Male; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome | 2004 |
Continuous infusion beta-lactams for intensive care unit pulmonary infections.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Computer Simulation; Drug Combinations; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; United States | 2005 |
Recurrent Alcaligenes xylosoxidans keratitis.
Topics: Abscess; Administration, Topical; Adult; Alcaligenes; Anti-Bacterial Agents; Ceftazidime; Corneal Transplantation; Gram-Negative Bacterial Infections; Humans; Keratitis; Male; Piperacillin; Recurrence; Reoperation | 2005 |
Intermittent administration of betalactam-antibiotics for treatment of severe infection in hemodialysis patients.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Cefepime; Ceftazidime; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Piperacillin; Renal Dialysis; Treatment Outcome | 2005 |
Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Topics: Aeromonas; Aged; Aged, 80 and over; Antineoplastic Agents; Bacteremia; Consciousness Disorders; Drug Resistance, Bacterial; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Hospitals; Humans; Imipenem; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Piperacillin; Prognosis; Risk Factors; Shock, Septic; Taiwan; Time Factors | 2006 |
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; beta-Lactams; Disease Models, Animal; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Lipopolysaccharides; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Proteins; Rats; Rats, Wistar; Shock, Septic | 2006 |
Primary bacteraemia caused by Rhizobium radiobacter in a patient with solid tumours.
Topics: Adult; Agrobacterium tumefaciens; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bone Neoplasms; Gram-Negative Bacterial Infections; Humans; Hydroxycorticosteroids; Male; Molecular Sequence Data; Osteosarcoma; Piperacillin; Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 16S | 2006 |
Bilateral simultaneous Achromobacter xylosoxidans keratitis following penetrating keratoplasty.
Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Keratoplasty, Penetrating; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Piperacillin; Quinolines | 2006 |
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Prospective Studies; Risk Factors | 2007 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |
[Infection with Aeromonas hydrophila after use of leeches (Hirudo medicinalis) in a free microvascular osteo-(myo-)cutaneous flap--suggestions for successful management].
Topics: Adult; Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Follow-Up Studies; Foot; Gram-Negative Bacterial Infections; Hirudo medicinalis; Humans; Leeching; Male; Penicillanic Acid; Piperacillin; Radiography; Surgical Flaps; Tazobactam; Time Factors; Treatment Outcome | 2007 |
Cefepime restriction improves gram-negative overall resistance patterns in neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins; Time Factors | 2007 |
Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clinical Protocols; Critical Care; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Incidence; Intensive Care Units; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Probability; Retrospective Studies; Sensitivity and Specificity; Tazobactam; Treatment Outcome | 2007 |
[Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
Topics: Anti-Bacterial Agents; Aztreonam; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Half-Life; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Sensitivity and Specificity | 2007 |
In vitro evaluation of newer beta-lactam antibiotics against gram negative bacilli isolated from neutropenic patients.
Topics: Anti-Bacterial Agents; Azlocillin; Clavulanic Acid; Clavulanic Acids; Drug Evaluation; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Neutropenia; Piperacillin; Pseudomonas aeruginosa; Sepsis; Ticarcillin | 1994 |
Studies on drug monitoring in thrice and once daily treatment with aminoglycosides.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fosfomycin; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Metronidazole; Middle Aged; Netilmicin; Piperacillin; Respiration, Artificial; Staphylococcal Infections; Teicoplanin | 1993 |
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections | 1997 |
[Severe diffuse facial cellulitis].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Bacterial Infections; Cause of Death; Cellulitis; Child; Drug Therapy, Combination; Face; Female; Forecasting; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Neck; Penicillins; Piperacillin; Premedication; Risk Factors; Treatment Outcome | 1997 |
[Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer].
Topics: Amikacin; Antineoplastic Agents; Breast Neoplasms; Drug Costs; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Neutropenia; Penicillanic Acid; Piperacillin; Spain; Tazobactam; Teicoplanin; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Vancomycin | 2000 |
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Infusions, Parenteral; Magainins; Male; Microbial Sensitivity Tests; Piperacillin; Rats; Rats, Wistar; Shock, Septic; Treatment Outcome; Xenopus Proteins | 2002 |
Capnocytophaga canimorus infection and acute renal failure.
Topics: Acute Kidney Injury; Capnocytophaga; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Multiple Organ Failure; Piperacillin; Sepsis | 1992 |